The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
WITHDRAWN: Survival outcomes and safety of opamtistomig (LBL-024), a novel PD-L1 and 4-1BB bispecific antibody, in combination with chemotherapy in treatment-naïve advanced extrapulmonary neuroendocrine carcinoma (EP-NEC): A phase Ib/II trial.
 
Panpan Zhang
No Relationships to Disclose
 
Ming Lu
No Relationships to Disclose
 
Bo Liu
No Relationships to Disclose
 
Yuping Sun
Honoraria - AstraZeneca; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Roche
Research Funding - Pfizer; Roche
 
Ning Li
No Relationships to Disclose
 
Jianwei Yang
No Relationships to Disclose
 
Shegan Gao
No Relationships to Disclose
 
Mudan Yang
No Relationships to Disclose
 
Ji Ma
No Relationships to Disclose
 
Yanqiao Zhang
No Relationships to Disclose
 
Yong Fang
No Relationships to Disclose
 
Jinghui Bai
No Relationships to Disclose
 
Peng Zhao
No Relationships to Disclose
 
Wenduo He
Employment - Leads Biolabs
Honoraria - Leads Biolabs
 
Ting Lv
Employment - Leads Biolabs
Honoraria - Leads Biolabs
 
Jing Xu
Employment - Leads Biolabs
Honoraria - Leads Biolabs
 
Bin Fan
Employment - Leads Biolabs
Honoraria - Leads Biolabs
 
Shengli Cai
Employment - Leads Biolabs
Leadership - Leads Biolabs
Honoraria - Leads Biolabs
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; SERVIER; Transcenta Holding Limited
Research Funding - BeiGene (Inst)